This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction: The Role of Atypical Antipsychotics in the Treatment of Bipolar Disorder

Robert M. A. Hirschfeld, MD

Published: March 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Bipolar disorder is a pernicious psychiatric illness with long-lasting effects on all aspectsof an affected individual’s life: social, family, and work. The most severe form of bipolar disorder, bipolar I, has a lifetime prevalence of 1%. The inclusion of less severeforms of the illness, such as bipolar II and cyclothymia, increases the prevalence of bipolardisorder to between 2% and 7%.1‘ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Bipolar Disorder

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...